Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph T Opferman

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Medicinal Chemistry|April 2, 2019
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human CancerTaekyu Lee, Plamen P Christov, Subrata Shaw, et al.
Cancer Discovery|February 17, 2021
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaVinod A Pullarkat, Norman J Lacayo, Elias Jabbour, et al.
Pediatric Blood & Cancer|April 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid LeukaemiaSeth E Karol, Seong L Khaw, C Michel Zwaan, et al.
Cell Death and Differentiation|April 26, 2023
Apoptotic cell death in disease-Current understanding of the NCCD 2023Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Medicinal Chemistry|April 2, 2019
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human CancerTaekyu Lee, Plamen P Christov, Subrata Shaw, et al.
Cancer Discovery|February 17, 2021
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaVinod A Pullarkat, Norman J Lacayo, Elias Jabbour, et al.
Pediatric Blood & Cancer|April 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid LeukaemiaSeth E Karol, Seong L Khaw, C Michel Zwaan, et al.
Cell Death and Differentiation|April 26, 2023
Apoptotic cell death in disease-Current understanding of the NCCD 2023Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Pageof 8